Ginkgo Bioworks Holdings Inc
NYSE:DNA

Watchlist Manager
Ginkgo Bioworks Holdings Inc Logo
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Watchlist
Price: 7.31 USD -15% Market Closed
Market Cap: 384.4m USD
Have any thoughts about
Ginkgo Bioworks Holdings Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Ginkgo Bioworks Holdings Inc

Current Assets 783.4m
Cash & Short-Term Investments 730.4m
Receivables 18.9m
Other Current Assets 34.1m
Non-Current Assets 841.9m
Long-Term Investments 62.5m
PP&E 628.6m
Intangibles 90.6m
Other Non-Current Assets 60.2m
Current Liabilities 166.2m
Accounts Payable 23m
Accrued Liabilities 117.1m
Other Current Liabilities 26m
Non-Current Liabilities 626m
Other Non-Current Liabilities 626m

Balance Sheet
Ginkgo Bioworks Holdings Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
495
381
1 550
1 316
944
Cash Equivalents
495
381
1 550
1 316
944
Total Receivables
9
24
150
84
32
Accounts Receivables
8
22
136
83
18
Other Receivables
1
2
14
2
14
Inventory
0
3
3
4
0
Other Current Assets
8
19
20
46
26
Total Current Assets
512
427
1 723
1 450
1 002
PP&E Net
63
121
146
716
397
PP&E Gross
63
121
146
716
397
Accumulated Depreciation
22
34
61
93
121
Intangible Assets
4
3
22
111
83
Goodwill
2
2
21
60
49
Note Receivable
4
13
0
0
14
Long-Term Investments
107
103
115
114
79
Other Long-Term Assets
6
6
44
89
42
Other Assets
2
2
21
60
49
Total Assets
697
N/A
675
-3%
2 071
+207%
2 539
+23%
1 665
-34%
Liabilities
Accounts Payable
2
14
8
11
9
Accrued Liabilities
14
28
93
115
110
Short-Term Debt
0
0
0
0
0
Current Portion of Long-Term Debt
1
1
0
0
0
Other Current Liabilities
23
31
33
48
44
Total Current Liabilities
40
73
135
173
164
Long-Term Debt
17
17
22
0
0
Minority Interest
9
9
62
0
0
Other Liabilities
139
115
347
630
404
Total Liabilities
204
N/A
214
+5%
566
+165%
803
+42%
568
-29%
Equity
Common Stock
0
0
0
0
0
Retained Earnings
341
468
2 298
4 398
5 291
Additional Paid In Capital
834
929
3 805
6 136
6 386
Other Equity
0
0
2
3
1
Total Equity
493
N/A
461
-6%
1 505
+226%
1 736
+15%
1 097
-37%
Total Liabilities & Equity
697
N/A
675
-3%
2 071
+207%
2 539
+23%
1 665
-34%
Shares Outstanding
Common Shares Outstanding
1 875
1 875
1 611
1 892
514

See Also

Discover More